Download PDF
Nuklearmedizin 2018; 57(01): 1-3
DOI: 10.3413/Nukmed-0947-17-11
Editorial
Schattauer GmbH

Propranolol und Morbus Parkinson

Was der Nuklearmediziner über den β2-Adrenorezeptor und das α-Synuclein-Gen wissen sollte
Markus Dietlein
1   Klinik und Poliklinik für Nuklearmedizin, Universitätsklinikum Köln
,
Felix Dietlein
2   Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
,
Alexander Drzezga
1   Klinik und Poliklinik für Nuklearmedizin, Universitätsklinikum Köln
› Author Affiliations
Further Information

Publication History

received: 25 November 2017

accepted in revised form: 15 December 2017

Publication Date:
21 February 2018 (online)

Also available at
    Permissions and Reprints

 

 

  • Literatur

  • 1 Dietlein M, Grünwald F, Schmidt M, Schneider P, Verburg FA, Luster M. Verfahrensanweisung zur Radioiodtherapie bei gutartigen Schilddrüsenerkrankungen (Version 5). Nuklearmedizin 2016; 55: 213-220.
    Thieme ConnectPubMedSearch in Google Scholar
  • 2 Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL. et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 2016; 26: 1343-1421.
    CrossrefPubMedSearch in Google Scholar
  • 3 Mittal S, Bjornevik K, Im DS, Flierl A, Dong X, Locasio JJ. et al. β2-Adrenoreceptor is a regulator of the –synuclein gene driving risk of Parkinson’s disease. Science 2017; 357: 891-898.
    CrossrefPubMedSearch in Google Scholar
  • 4 Snyder EY. Finding a new purpose for old drugs. Drugs used for the treatment of asthma might prevent Parkinson’s disease. Science 2017; 357: 869-870.
    CrossrefPubMedSearch in Google Scholar
  • 5 Alves G, Müller B, Herlofson K, Hogen IEsch, Telstad W, Aarsland D. et al. Incidence of Parkinson’s disease in Norway: The Norwegian ParkWest study. J Neurol Neurosurg Psychiatry 2009; 80: 851-857.
    CrossrefPubMedSearch in Google Scholar
  • 6 Hughes KC, Gao X, Kim IY, Wang M, Weisskopf MG, Schwarzschild MA, Ascherio A. Intake of dairy foods and risk of Parkinson disease. Neurology 2017; 89: 46-52.
    CrossrefPubMedSearch in Google Scholar
  • 7 Park M, Ross GW, Petrovitch H. et al. Consumption of milk and calcium in midlife and the future risk of Parkinson disease. Neurology 2005; 64: 1047-1051.
    CrossrefPubMedSearch in Google Scholar
  • 8 Chen H, O’Reilly E, McCullough ML. et al. Consumption of dairy products and risk of Parkinson’s disease. Am J Epidemiol 2007; 165: 998-1006.
    CrossrefPubMedSearch in Google Scholar
  • 9 Saaksjarvi K, Knekt P, Lundqvist A. et al. A cohort study on diet and the risk of Parkinson’s disease: the role of food groups and diet quality. Br J Nutr 2013; 109: 329-337.
    CrossrefPubMedSearch in Google Scholar